Elgendy and colleagues reported that PPA2 activated the downstream glycogen synthase kinase 3β (GSK3β), which led to the decline of pro-survival protein MCL-1 and mediated metformin-induced gastric cancer cell death [15]. This evidence concerns the gene GSK3B and gastric cancer.